LMBR1L Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA526795-Each-of-1 | In Stock | ₹ 48,193.50 |
PIPA526795 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 48,193.50
GST (18%): ₹ 8,674.83
Total Price: ₹ 56,868.33
Antigen
LMBR1L
Classification
Polyclonal
Conjugate
Unconjugated
Gene
LMBR1L
Gene Alias
1110013E13Rik; AA415653; D15Ertd735e; KIAA1174; limb development membrane protein 1 like; limb development membrane protein 1-like; limb region 1 homolog-like; limb region 1 like; limb region 1 protein homolog-like; limb region 1-like homolog; limb region 1-like protein -like; LIMR; lipocalin-1 interacting membrane receptor; lipocalin-1-interacting membrane receptor; lipocalin-interacting membrane receptor; Lmbr1l; Protein LMBR1L; RGD1309631; UNQ458/PRO783; Uteroglobin receptor
Host Species
Rabbit
Purification Method
Antigen affinity chromatography, Protein A
Regulatory Status
RUO
Gene ID (Entrez)
55716
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Applications
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot
Concentration
0.5 mg/mL
Formulation
PBS with 0.09% sodium azide
Gene Accession No.
Q6UX01
Gene Symbols
LMBR1L
Immunogen
KLH conjugated synthetic peptide between 462-489 amino acids from the C-terminal region of human LMBR1L
Quantity
400 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Related Products
Description
- LMBR1L, also known as LIMR (lipocalin-1-interacting membrane receptor), interacts with lipocalin-1 (Lcn-1), a lipocalin member produced by a number of secretory glands and tissues and known to bind a variety of lipophilic compounds
- LMBR1L is a 489-amino acid protein with a predicted molecular mass of 55 kDa and 9 putative transmembrane helices
- LMBR1L has been shown to mediate cellular uptake of LMBR1L, thus it is characterized as a endocytic receptor
- Alternatively spliced transcript variants encoding different isoforms have been described.